Solution for injection 10mg/5ml, 50mg/25ml, 200mg/100ml

Epirubicin is used in the treatment of a range of neoplastic conditions including:

  • Carcinoma of the breast
  • Advanced ovarian cancer
  • Gastric cancer
  • Small cell lung cancer

When administered intravesically, epirubicin has been shown to be beneficial in the treatment of:

  • Papillary transitional cell carcinoma of the bladder
  • Carcinoma-in-situ of the bladder
  • Intravesical prophylaxis of recurrences of superficial bladder carcinoma following transurethral resection.